This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 8 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: The Innovations of Lars Van Der Veen
Introduction
Lars Van Der Veen is a notable inventor based in Alsbach-Haehnlein, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating diseases characterized by excessive or abnormal cell proliferation. With a total of six patents to his name, Van Der Veen's work is recognized for its potential impact on healthcare.
Latest Patents
Among his latest patents are two significant inventions. The first is related to 5-alkynyl-pyrimidines, which encompasses compounds of general formula (1) suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation. This invention also includes the use of these compounds for preparing a medicament with the aforementioned properties. The second patent involves thia-triaza-indacenes, which similarly includes compounds of general formula (1) that are defined for treating diseases characterized by excessive or abnormal cell proliferation, along with their application in creating a medicament.
Career Highlights
Lars Van Der Veen is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at Boehringer Ingelheim focuses on innovative solutions in drug development, particularly in the area of oncology. His expertise and dedication have contributed to the advancement of therapeutic options for patients.
Collaborations
Throughout his career, Van Der Veen has collaborated with several talented professionals, including Siegfried Schneider and Tobias Wunberg. These collaborations have fostered a productive environment for innovation and have led to the successful development of new medicinal compounds.
Conclusion
Lars Van Der Veen's contributions to the field of medicinal chemistry are noteworthy, with his patents reflecting a commitment to addressing critical health challenges. His work continues to inspire advancements in the treatment of diseases characterized by abnormal cell proliferation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile